Metavasi Capital’s Crocs CROX Stock Holding History

Metavasi Capital’s Portfolio CROX Stock Details CROX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,000	Closed	-$2.17M	–	34
2024 Q3	$2.17M	Buy	+15,000	New	+$2.05M	0.99%	26

Other funds holding CROX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WPA

WIT Partners Advisory Singapore $342M AUM 8.23% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metavasi Capital's CROX Position: Q4 2024 in Review

Metavasi Capital sold out of Crocs (CROX) in Q4 2024, closing a stake of 15,000 shares — an estimated $2.17M sold.

Metavasi Capital first reported a position in CROX in Q3 2024 and held it in 1 quarter. The position peaked at $2.17M in Q3 2024. 496 funds tracked by Wall St. Rank hold CROX as of Q4 2024.

Metavasi Capital reported no remaining Crocs position as of Q4 2024 after selling out during the quarter.
Metavasi Capital sold 15,000 Crocs shares in Q4 2024, an estimated $2.17M.
Metavasi Capital first reported a position in Crocs in Q3 2024 and held it in 1 quarter.
Metavasi Capital's Crocs position peaked at $2.17M in Q3 2024.
496 funds tracked by Wall St. Rank held Crocs as of Q4 2024.

Based on Metavasi Capital's 13F filing for Q4 2024, filed 14 Feb 2025.